Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 512

1.

Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people.

Alqarni A, Mitchell TW, McGorry PD, Nelson B, Markulev C, Yuen HP, Schäfer MR, Berger M, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, Amminger GP, Meyer BJ.

Schizophr Res. 2019 Jul 10. pii: S0920-9964(19)30241-5. doi: 10.1016/j.schres.2019.06.020. [Epub ahead of print]

PMID:
31301881
2.

The case for improved care and provision of treatment for people with first-episode mania.

Jauhar S, Ratheesh A, Davey C, Yatham LN, McGorry PD, McGuire P, Berk M, Young AH.

Lancet Psychiatry. 2019 Jun 24. pii: S2215-0366(19)30082-3. doi: 10.1016/S2215-0366(19)30082-3. [Epub ahead of print] Review.

PMID:
31248840
3.

Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial.

Berger M, Nelson B, Markulev C, Yuen HP, Schäfer MR, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, McGorry PD, Amminger GP.

Front Psychiatry. 2019 Jun 6;10:393. doi: 10.3389/fpsyt.2019.00393. eCollection 2019.

4.

Effectiveness of universal programmes for the prevention of suicidal ideation, behaviour and mental ill health in medical students: a systematic review and meta-analysis.

Witt K, Boland A, Lamblin M, McGorry PD, Veness B, Cipriani A, Hawton K, Harvey S, Christensen H, Robinson J.

Evid Based Ment Health. 2019 May;22(2):84-90. doi: 10.1136/ebmental-2019-300082. Epub 2019 Mar 27. Review.

PMID:
30918000
5.

Early intervention for depression in young people: a blind spot in mental health care - Authors' reply.

Davey CG, McGorry PD.

Lancet Psychiatry. 2019 Apr;6(4):283-284. doi: 10.1016/S2215-0366(19)30081-1. No abstract available.

PMID:
30904118
6.

HORYZONS trial: protocol for a randomised controlled trial of a moderated online social therapy to maintain treatment effects from first-episode psychosis services.

Alvarez-Jimenez M, Bendall S, Koval P, Rice S, Cagliarini D, Valentine L, D'Alfonso S, Miles C, Russon P, Penn DL, Phillips J, Lederman R, Wadley G, Killackey E, Santesteban-Echarri O, Mihalopoulos C, Herrman H, Gonzalez-Blanch C, Gilbertson T, Lal S, Chambers R, Daglas-Georgiou R, Latorre C, Cotton SM, McGorry PD, Gleeson JF.

BMJ Open. 2019 Feb 19;9(2):e024104. doi: 10.1136/bmjopen-2018-024104.

7.

The Vitamins in Psychosis Study: A Randomized, Double-Blind, Placebo-Controlled Trial of the Effects of Vitamins B12, B6, and Folic Acid on Symptoms and Neurocognition in First-Episode Psychosis.

Allott K, McGorry PD, Yuen HP, Firth J, Proffitt TM, Berger G, Maruff P, O'Regan MK, Papas A, Stephens TCB, O'Donnell CP.

Biol Psychiatry. 2019 Jul 1;86(1):35-44. doi: 10.1016/j.biopsych.2018.12.018. Epub 2019 Jan 9.

PMID:
30771856
8.

Frontal slow wave resting EEG power is higher in individuals at Ultra High Risk for psychosis than in healthy controls but is not associated with negative symptoms or functioning.

Sollychin M, Jack BN, Polari A, Ando A, Amminger GP, Markulev C, McGorry PD, Nelson B, Whitford TJ, Yuen HP, Lavoie S.

Schizophr Res. 2019 Jun;208:293-299. doi: 10.1016/j.schres.2019.01.039. Epub 2019 Feb 6.

PMID:
30738699
9.

Importance of Variable Selection in Multimodal Prediction Models in Patients at Clinical High Risk for Psychosis and Recent-Onset Depression.

Nelson B, Yung AR, McGorry PD.

JAMA Psychiatry. 2019 Feb 6. doi: 10.1001/jamapsychiatry.2018.4234. [Epub ahead of print] No abstract available.

PMID:
30725086
10.

Staging model in psychiatry: Review of the evolution of electroencephalography abnormalities in major psychiatric disorders.

Lavoie S, Polari AR, Goldstone S, Nelson B, McGorry PD.

Early Interv Psychiatry. 2019 Jan 27. doi: 10.1111/eip.12792. [Epub ahead of print] Review.

PMID:
30688016
11.

Testing a neurophenomenological model of basic self disturbance in early psychosis.

Nelson B, Lavoie S, Gaweda L, Li E, Sass LA, Koren D, McGorry PD, Jack BN, Parnas J, Polari A, Allott K, Hartmann JA, Whitford TJ.

World Psychiatry. 2019 Feb;18(1):104-105. doi: 10.1002/wps.20597. No abstract available.

12.

Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial.

Bolt LK, Amminger GP, Farhall J, McGorry PD, Nelson B, Markulev C, Yuen HP, Schäfer MR, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, Allott KA.

Schizophr Res. 2019 Apr;206:67-74. doi: 10.1016/j.schres.2018.12.013. Epub 2018 Dec 14.

PMID:
30558978
13.

Dynamic prediction of transition to psychosis using joint modelling.

Yuen HP, Mackinnon A, Hartmann J, Amminger GP, Markulev C, Lavoie S, Schäfer MR, Polari A, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger G, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, McGorry PD, Nelson B.

Schizophr Res. 2018 Dec;202:333-340. doi: 10.1016/j.schres.2018.07.002. Epub 2018 Jul 7.

PMID:
30539771
14.

Early intervention for depression in young people: a blind spot in mental health care.

Davey CG, McGorry PD.

Lancet Psychiatry. 2019 Mar;6(3):267-272. doi: 10.1016/S2215-0366(18)30292-X. Epub 2018 Nov 27. Review.

PMID:
30502077
15.

Hippocampal subfields and visuospatial associative memory across stages of schizophrenia-spectrum disorder.

Wannan CMJ, Cropley VL, Chakravarty MM, Van Rheenen TE, Mancuso S, Bousman C, Everall I, McGorry PD, Pantelis C, Bartholomeusz CF.

Psychol Med. 2018 Dec 4:1-11. doi: 10.1017/S0033291718003458. [Epub ahead of print]

PMID:
30511607
16.

Can youth at high risk of illness progression be identified by measures of rumination and sleep-wake disturbance.

Grierson AB, Scott J, Glozier N, Hickie IB, Amminger PG, Killackey E, McGorry PD, Pantelis C, Phillips L, Scott E, Yung AR, Purcell R.

Early Interv Psychiatry. 2018 Nov 28. doi: 10.1111/eip.12757. [Epub ahead of print]

PMID:
30485651
17.

Persistent negative symptoms in individuals at Ultra High Risk for psychosis.

Yung AR, Nelson B, McGorry PD, Wood SJ, Lin A.

Schizophr Res. 2019 Apr;206:355-361. doi: 10.1016/j.schres.2018.10.019. Epub 2018 Oct 26.

18.

Recent Meta-Analyses in the Clinical High Risk for Psychosis Population: Clinical Interpretation of Findings and Suggestions for Future Research.

Nelson B, Amminger GP, McGorry PD.

Front Psychiatry. 2018 Oct 12;9:502. doi: 10.3389/fpsyt.2018.00502. eCollection 2018. No abstract available.

19.

Ultra-high-risk paradigm: lessons learnt and new directions.

McGorry PD, Mei C.

Evid Based Ment Health. 2018 Nov;21(4):131-133. doi: 10.1136/ebmental-2018-300061. Epub 2018 Oct 24. Review.

PMID:
30355661
20.

Early intervention in youth mental health: progress and future directions.

McGorry PD, Mei C.

Evid Based Ment Health. 2018 Nov;21(4):182-184. doi: 10.1136/ebmental-2018-300060. Epub 2018 Oct 23. Review.

PMID:
30352884
21.

Current versus recently resolved attenuated psychotic symptoms: Same level of risk for transition to psychosis?

Rice SM, McGorry PD, Amminger GP, Nelson B.

Schizophr Res. 2019 Feb;204:450-451. doi: 10.1016/j.schres.2018.09.023. Epub 2018 Oct 19. No abstract available.

PMID:
30344054
22.

Relationship between allostatic load and clinical outcomes in youth at ultra-high risk for psychosis in the NEURAPRO study.

Berger M, Lavoie S, McGorry PD, Nelson B, Markulev C, Yuen HP, Schaefer M, Sarnyai Z, Amminger GP.

Schizophr Res. 2018 Oct 16. pii: S0920-9964(18)30604-2. doi: 10.1016/j.schres.2018.10.002. [Epub ahead of print]

PMID:
30340917
23.

Longitudinal Cognitive Performance in Individuals at Ultrahigh Risk for Psychosis: A 10-year Follow-up.

Allott K, Wood SJ, Yuen HP, Yung AR, Nelson B, Brewer WJ, Spiliotacopoulos D, Bruxner A, Simmons M, Broussard C, Mallawaarachchi S, Pantelis C, McGorry PD, Lin A.

Schizophr Bull. 2018 Oct 13. doi: 10.1093/schbul/sby143. [Epub ahead of print]

PMID:
30321434
24.

Individual placement and support for vocational recovery in first-episode psychosis: randomised controlled trial.

Killackey E, Allott K, Jackson HJ, Scutella R, Tseng YP, Borland J, Proffitt TM, Hunt S, Kay-Lambkin F, Chinnery G, Baksheev G, Alvarez-Jimenez M, McGorry PD, Cotton SM.

Br J Psychiatry. 2019 Feb;214(2):76-82. doi: 10.1192/bjp.2018.191. Epub 2018 Sep 25.

PMID:
30251616
25.

Tackling the youth mental health crisis across adolescence and young adulthood.

McGorry PD, Mei C.

BMJ. 2018 Sep 6;362:k3704. doi: 10.1136/bmj.k3704. No abstract available.

PMID:
30190368
26.

Enhancing social functioning in young people at Ultra High Risk (UHR) for psychosis: A pilot study of a novel strengths and mindfulness-based online social therapy.

Alvarez-Jimenez M, Gleeson JF, Bendall S, Penn DL, Yung AR, Ryan RM, Eleftheriadis D, D'Alfonso S, Rice S, Miles C, Russon P, Lederman R, Chambers R, Gonzalez-Blanch C, Lim MH, Killackey E, McGorry PD, Nelson B.

Schizophr Res. 2018 Dec;202:369-377. doi: 10.1016/j.schres.2018.07.022. Epub 2018 Jul 18.

PMID:
30031616
27.

NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders-medium-term follow-up and clinical course.

Nelson B, Amminger GP, Yuen HP, Markulev C, Lavoie S, Schäfer MR, Hartmann JA, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger G, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, McGorry PD.

NPJ Schizophr. 2018 Jun 25;4(1):11. doi: 10.1038/s41537-018-0052-x.

28.

At-risk studies and clinical antecedents of psychosis, bipolar disorder and depression: a scoping review in the context of clinical staging.

Hartmann JA, Nelson B, Ratheesh A, Treen D, McGorry PD.

Psychol Med. 2019 Jan;49(2):177-189. doi: 10.1017/S0033291718001435. Epub 2018 Jun 4.

PMID:
29860956
29.

Beyond the "at risk mental state" concept: transitioning to transdiagnostic psychiatry.

McGorry PD, Hartmann JA, Spooner R, Nelson B.

World Psychiatry. 2018 Jun;17(2):133-142. doi: 10.1002/wps.20514.

30.

Resting-state functional brain networks in first-episode psychosis: A 12-month follow-up study.

Ganella EP, Seguin C, Pantelis C, Whittle S, Baune BT, Olver J, Amminger GP, McGorry PD, Cropley V, Zalesky A, Bartholomeusz CF.

Aust N Z J Psychiatry. 2018 Sep;52(9):864-875. doi: 10.1177/0004867418775833. Epub 2018 May 27.

PMID:
29806483
31.

Early Intervention-An Implementation Challenge for 21st Century Mental Health Care.

McGorry PD, Ratheesh A, O'Donoghue B.

JAMA Psychiatry. 2018 Jun 1;75(6):545-546. doi: 10.1001/jamapsychiatry.2018.0621. No abstract available.

PMID:
29801060
32.

Preventive strategies for mental health.

Arango C, Díaz-Caneja CM, McGorry PD, Rapoport J, Sommer IE, Vorstman JA, McDaid D, Marín O, Serrano-Drozdowskyj E, Freedman R, Carpenter W.

Lancet Psychiatry. 2018 Jul;5(7):591-604. doi: 10.1016/S2215-0366(18)30057-9. Epub 2018 May 15. Review.

PMID:
29773478
33.

'Is "early intervention" in bipolar disorder what it claims to be?' Malhi et al.

McGorry PD, Ratheesh A, Berk M, Conus P.

Bipolar Disord. 2018 May;20(3):181-183. doi: 10.1111/bdi.12641. No abstract available.

PMID:
29737634
34.

Adolescent and Young Adult Male Mental Health: Transforming System Failures Into Proactive Models of Engagement.

Rice SM, Purcell R, McGorry PD.

J Adolesc Health. 2018 Mar;62(3S):S9-S17. doi: 10.1016/j.jadohealth.2017.07.024. Review.

35.

Stress hormones and verbal memory in young people over the first 12 weeks of treatment for psychosis.

Allott KA, Yuen HP, Bartholomeusz CF, Rapado-Castro M, Phassouliotis C, Butselaar F, Wood SJ, Proffitt TM, Savage G, Phillips LJ, Bendall S, Markulev C, Reniers RLEP, Pantelis C, Baldwin L, McGorry PD, Garner B.

Psychiatry Res. 2018 Feb;260:60-66. doi: 10.1016/j.psychres.2017.11.044. Epub 2017 Nov 21.

PMID:
29175500
36.

Duration of untreated psychosis and neurocognitive functioning in first-episode psychosis: a systematic review and meta-analysis.

Allott K, Fraguas D, Bartholomeusz CF, Díaz-Caneja CM, Wannan C, Parrish EM, Amminger GP, Pantelis C, Arango C, McGorry PD, Rapado-Castro M.

Psychol Med. 2018 Jul;48(10):1592-1607. doi: 10.1017/S0033291717003002. Epub 2017 Nov 27.

PMID:
29173201
37.

Impaired mismatch negativity to frequency deviants in individuals at ultra-high risk for psychosis, and preliminary evidence for further impairment with transition to psychosis.

Lavoie S, Jack BN, Griffiths O, Ando A, Amminger P, Couroupis A, Jago A, Markulev C, McGorry PD, Nelson B, Polari A, Yuen HP, Whitford TJ.

Schizophr Res. 2018 Jan;191:95-100. doi: 10.1016/j.schres.2017.11.005. Epub 2017 Nov 11.

PMID:
29132815
38.

Identifying attributes of care that may improve cost-effectiveness in the youth mental health service system.

Hamilton MP, Hetrick SE, Mihalopoulos C, Baker D, Browne V, Chanen AM, Pennell K, Purcell R, Stavely H, McGorry PD.

Med J Aust. 2017 Nov 20;207(10):S27-S37. Review.

PMID:
29129184
39.

Targeting mental health care attributes by diagnosis and clinical stage: the views of youth mental health clinicians.

Hamilton MP, Hetrick SE, Mihalopoulos C, Baker D, Browne V, Chanen AM, Pennell K, Purcell R, Stavely H, McGorry PD.

Med J Aust. 2017 Nov 20;207(10):S19-S26.

PMID:
29129183
40.

Integrated (one-stop shop) youth health care: best available evidence and future directions.

Hetrick SE, Bailey AP, Smith KE, Malla A, Mathias S, Singh SP, O'Reilly A, Verma SK, Benoit L, Fleming TM, Moro MR, Rickwood DJ, Duffy J, Eriksen T, Illback R, Fisher CA, McGorry PD.

Med J Aust. 2017 Nov 20;207(10):S5-S18. Review.

PMID:
29129182
41.

Youth mental health: building beyond the brand.

McGorry PD.

Med J Aust. 2017 Nov 20;207(10):428-429. No abstract available.

PMID:
29129173
42.

The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo.

McHugh MJ, McGorry PD, Yuen HP, Hickie IB, Thompson A, de Haan L, Mossaheb N, Smesny S, Lin A, Markulev C, Schloegelhofer M, Wood SJ, Nieman D, Hartmann JA, Nordentoft M, Schäfer M, Amminger GP, Yung A, Nelson B.

Schizophr Res. 2018 May;195:543-548. doi: 10.1016/j.schres.2017.09.003. Epub 2017 Oct 19.

PMID:
29055567
43.

Broad clinical high-risk mental state (CHARMS): Methodology of a cohort study validating criteria for pluripotent risk.

Hartmann JA, Nelson B, Spooner R, Paul Amminger G, Chanen A, Davey CG, McHugh M, Ratheesh A, Treen D, Yuen HP, McGorry PD.

Early Interv Psychiatry. 2019 Jun;13(3):379-386. doi: 10.1111/eip.12483. Epub 2017 Oct 5.

PMID:
28984077
44.

Staging in bipolar disorder: from theoretical framework to clinical utility.

Berk M, Post R, Ratheesh A, Gliddon E, Singh A, Vieta E, Carvalho AF, Ashton MM, Berk L, Cotton SM, McGorry PD, Fernandes BS, Yatham LN, Dodd S.

World Psychiatry. 2017 Oct;16(3):236-244. doi: 10.1002/wps.20441.

45.

Improving outcomes of first-episode psychosis: an overview.

Fusar-Poli P, McGorry PD, Kane JM.

World Psychiatry. 2017 Oct;16(3):251-265. doi: 10.1002/wps.20446.

46.

Broken promises and missing steps in mental health reform.

McGorry PD, Hamilton MP.

Med J Aust. 2017 Jun 19;206(11):487-489. No abstract available.

PMID:
28918731
47.

Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for Psychosis.

Hartmann JA, McGorry PD, Schmidt SJ, Amminger GP, Yuen HP, Markulev C, Berger GE, Chen EYH, de Haan L, Hickie IB, Lavoie S, McHugh MJ, Mossaheb N, Nieman DH, Nordentoft M, Riecher-Rössler A, Schäfer MR, Schlögelhofer M, Smesny S, Thompson A, Verma SK, Yung AR, Nelson B.

Psychother Psychosom. 2017;86(5):292-299. doi: 10.1159/000477551. Epub 2017 Sep 14.

48.

PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia.

Di Biase MA, Zalesky A, O'keefe G, Laskaris L, Baune BT, Weickert CS, Olver J, McGorry PD, Amminger GP, Nelson B, Scott AM, Hickie I, Banati R, Turkheimer F, Yaqub M, Everall IP, Pantelis C, Cropley V.

Transl Psychiatry. 2017 Aug 29;7(8):e1225. doi: 10.1038/tp.2017.193.

49.

Omega-6 to omega-3 polyunsaturated fatty acid ratio and subsequent mood disorders in young people with at-risk mental states: a 7-year longitudinal study.

Berger ME, Smesny S, Kim SW, Davey CG, Rice S, Sarnyai Z, Schlögelhofer M, Schäfer MR, Berk M, McGorry PD, Amminger GP.

Transl Psychiatry. 2017 Aug 29;7(8):e1220. doi: 10.1038/tp.2017.190.

50.

Predictors of longer-term outcome in the Vienna omega-3 high-risk study.

Mossaheb N, Schäfer MR, Schlögelhofer M, Klier CM, Smesny S, McGorry PD, Berger M, Amminger GP.

Schizophr Res. 2018 Mar;193:168-172. doi: 10.1016/j.schres.2017.08.010. Epub 2017 Aug 18.

PMID:
28823721

Supplemental Content

Loading ...
Support Center